{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:49:03Z","timestamp":1790686143301,"version":"4.1.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"Importance<\/jats:title>There is a paucity of information on the association between clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular disease (CVD) in patients with cancer, including those with multiple myeloma (MM) undergoing hematopoietic cell transplant (HCT), a population at high risk of developing CVD after HCT.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine the association between CHIP and CVD in patients with MM and to describe modifiers of CVD risk among those with CHIP.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This was a retrospective cohort study of patients with MM who underwent HCT between 2010 and 2016 at City of Hope Comprehensive Cancer Center in Duarte, California, and had pre-HCT mobilized peripheral blood stem cell (PBSC) products cryopreserved and accessible for CHIP analyses. The study team performed targeted panel DNA sequencing to detect the presence of CHIP (variant allele frequency 2% or more).<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary end point was the 5-year cumulative incidence and risk for developing de novo CVD (heart failure, coronary artery disease, or stroke) after HCT.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 1036 consecutive patients with MM (580 male [56%]; median age, 60.0 years) who underwent a first autologous HCT, 201 patients had at least 1 CHIP variant (19.4%) and 35 patients had 2 or more variants (3.4%). The 5-year incidence of CVD was significantly higher in patients with CHIP (21.1% vs 8.4%; P<\/jats:italic>\u2009&amp;lt;\u2009.001) compared with those without CHIP; the 5-year incidence among those with 2 or more variants was 25.6%. In the multivariable model, CHIP was associated with increased risk of CVD (hazard ratio [HR], 2.72; 95% CI, 1.70-4.39), as well as of individual outcomes of interest, including heart failure (HR, 4.02; 95% CI, 2.32-6.98), coronary artery disease (HR, 2.22; 95% CI, 1.06-4.63), and stroke (HR, 3.02; 95% CI, 1.07-8.52). Patients who had both CHIP and preexisting hypertension or dyslipidemia were at nearly 7-fold and 4-fold increased risk of CVD, respectively (reference: no CHIP, no hypertension, or dyslipidemia).<\/jats:p><\/jats:sec>Conclusion and Relevance<\/jats:title>CHIP was significantly and independently associated with risk of CVD in patients with MM undergoing HCT and may serve as a novel biologically plausible biomarker for CVD in this cohort. Patients with MM and both CHIP and cardiovascular risk factors had an exceptionally high risk of CVD. Additional studies are warranted to determine if cardiovascular preventive measures can reduce CHIP-associated CVD risk.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamacardio.2023.4105","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T16:02:57Z","timestamp":1699459377000},"page":"16","source":"Crossref","is-referenced-by-count":39,"title":["Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant"],"prefix":"10.1001","volume":"9","author":[{"given":"June-Wha","family":"Rhee","sequence":"first","affiliation":[{"name":"Department of Medicine, City of Hope Comprehensive Cancer Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Pillai","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"He","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysia","family":"Bosworth","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liezl","family":"Atencio","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Oganesyan","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tati","family":"Guzman","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Lukas","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Sigala","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksi","family":"Iukuridze","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanie","family":"Lindenfeld","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizi","family":"Jamal","sequence":"additional","affiliation":[{"name":"Department of Medicine, City of Hope Comprehensive Cancer Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Natarajan","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Goldsmith","sequence":"additional","affiliation":[{"name":"Department of Hematology & Hematopoietic Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Hematology & Hematopoietic Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rosenzweig","sequence":"additional","affiliation":[{"name":"Department of Hematology & Hematopoietic Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Lennie","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[{"name":"Department of Hematology & Hematopoietic Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saro","family":"Armenian","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte California"},{"name":"Department of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"17","key":"hoi230057r1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation.","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"hoi230057r2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.6004\/jnccn.2022.0002","article-title":"NCCN guidelines insights: multiple myeloma, version 3.2022.","volume":"20","author":"Callander","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"hoi230057r3","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States.","volume":"26","author":"D\u2019Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"hoi230057r4","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood"},{"issue":"16","key":"hoi230057r5","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.","volume":"29","author":"Wingard","year":"2011","journal-title":"J Clin Oncol"},{"issue":"14","key":"hoi230057r6","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1182\/bloodadvances.2018019117","article-title":"Prediction of cardiovascular disease among hematopoietic cell transplantation survivors.","volume":"2","author":"Armenian","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"hoi230057r7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/cncr.v120.4","article-title":"Cardiovascular disease in survivors of hematopoietic cell transplantation.","volume":"120","author":"Armenian","year":"2014","journal-title":"Cancer"},{"issue":"26","key":"hoi230057r8","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes.","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"hoi230057r9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease.","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"6327","key":"hoi230057r10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"issue":"1","key":"hoi230057r11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jacc.2021.04.085","article-title":"Supplemental association of clonal hematopoiesis with incident heart failure.","volume":"78","author":"Yu","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi230057r12","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/STROKEAHA.121.037388","article-title":"Clonal hematopoiesis is associated with higher risk of stroke.","volume":"53","author":"Bhattacharya","year":"2022","journal-title":"Stroke"},{"issue":"3","key":"hoi230057r13","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1111\/bjh.2019.186.issue-3","article-title":"Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy.","volume":"186","author":"Olszewski","year":"2019","journal-title":"Br J Haematol"},{"issue":"8","key":"hoi230057r14","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"4","key":"hoi230057r15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/leu.2012.336","article-title":"Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.","volume":"27","author":"Fern\u00e1ndez de Larrea","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"hoi230057r16","doi-asserted-by":"publisher","DOI":"10.1161\/HCQ.0000000000000102","article-title":"2021 ACC\/AHA key data elements and definitions for heart failure: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).","volume":"14","author":"Bozkurt","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"hoi230057r17","doi-asserted-by":"publisher","DOI":"10.1161\/HCQ.0000000000000112","article-title":"2022 ACC\/AHA Key data elements and definitions for chest pain and acute myocardial infarction: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Data Standards.","author":"Anderson","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"hoi230057r18","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"issue":"1","key":"hoi230057r19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"5","key":"hoi230057r20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"hoi230057r21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"issue":"14","key":"hoi230057r22","first-page":"1401","article-title":"Clonal hematopoiesis and atherosclerosis.","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"hoi230057r23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1200\/EDBK_239083","article-title":"CHIP, CCUS, and other acronyms: definition, implications, and impact on Practice.","volume":"39","author":"DeZern","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"446","key":"hoi230057r24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"hoi230057r25","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1038\/s41467-020-16805-5","article-title":"Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.","volume":"11","author":"Mouhieddine","year":"2020","journal-title":"Nat Commun"},{"issue":"14","key":"hoi230057r26","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma.","volume":"35","author":"Gibson","year":"2017","journal-title":"J Clin Oncol"},{"issue":"10","key":"hoi230057r27","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/bmt.2016.141","article-title":"Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation.","volume":"51","author":"Elsawy","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"hoi230057r28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41598-021-04308-2","article-title":"Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.","volume":"12","author":"Bick","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"hoi230057r29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.051775","article-title":"Premature menopause, clonal hematopoiesis, and coronary artery disease in postmenopausal women.","volume":"143","author":"Honigberg","year":"2021","journal-title":"Circulation"},{"issue":"19","key":"hoi230057r30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026154","article-title":"Experimental ASXL1-mediated clonal hematopoiesis promotes inflammation and accelerates heart failure.","volume":"11","author":"Min","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"hoi230057r31","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/HYPERTENSIONAHA.121.18315","article-title":"Risk-based intensive blood pressure lowering and prevention of heart failure: a SPRINT Post Hoc Analysis.","volume":"78","author":"Molsberry","year":"2021","journal-title":"Hypertension"},{"issue":"1","key":"hoi230057r32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12979-022-00278-9","article-title":"Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics.","volume":"19","author":"Uddin","year":"2022","journal-title":"Immun Ageing"},{"issue":"7339","key":"hoi230057r33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma.","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2811495\/jamacardiology_rhee_2023_oi_230057_1703114497.26686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T16:02:07Z","timestamp":1704902527000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2811495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2023.4105","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}